Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Evogene Ltd Ord (EVGN)

Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders

Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by leveraging generative chemistry design and patient-derived predictive platform...

EVGN : 1.0599 (+2.90%)
Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development

REHOVOT, Israel , Dec. 30, 2025 /PRNewswire/ --  Evogene Ltd . (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative design of small molecules...

EVGN : 1.0599 (+2.90%)
Evogene: Q3 Earnings Snapshot

Evogene: Q3 Earnings Snapshot

EVGN : 1.0599 (+2.90%)
Evogene Reports Third Quarter 2025 Financial Results

Conference call and webcast: today, November 20, 2025, 9:00 AM ET

EVGN : 1.0599 (+2.90%)
Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming

Collaboration focuses on integrating high-yield castor varieties with advanced mechanized solutions, including harvesting and threshing technologies

EVGN : 1.0599 (+2.90%)
Evogene Schedules Third Quarter 2025 Financial Results Release

Zoom conference call scheduled for November 20, 2025, 9:00 AM ET

EVGN : 1.0599 (+2.90%)
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York

REHOVOT, Israel , Aug. 28, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ : EVGN) (TASE: EVGN), a leading computational biology and chemistry company, today announced that Ofer...

EVGN : 1.0599 (+2.90%)
Evogene: Q2 Earnings Snapshot

Evogene: Q2 Earnings Snapshot

EVGN : 1.0599 (+2.90%)
Evogene Reports Second Quarter 2025 Financial Results

Conference call and webcast: today, August 19, 2025 , 9:00 am ET

EVGN : 1.0599 (+2.90%)
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases

A failure in metabolite breakdown leads to their ordered self-assembly into pathological aggregates, such as in Tyrosinemia   and Gout.

EVGN : 1.0599 (+2.90%)

Barchart Exclusives

HSBC Says These 2 AI Stocks Are Likely to Be Earnings Winners. Should You Buy Them Now?
Beaten-down large-cap stocks such as Salesforce and Oracle have significant upside potential given their estimated growth rates. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar